Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
InNexus Biotechnology, Inc.
O
OTC:IXSBF
OTC Markets
- -
USD
- -
- -
InNexus Biotechnology, Inc.
OTC:IXSBF
(OTC Markets)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
TTM
CAD
0.01
0.02
- -
- -
0.02
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.02
-0.08
-0.08
-0.06
-0.06
-0.1
-0.12
-0.12
-0.11
-0.11
-0.07
-0.03
Basic EPS, GAAP
-0.02
-0.07
-0.07
-0.09
-0.08
-0.08
-0.11
-0.07
-0.17
-0.05
-0.02
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.1
-0.18
-0.23
-0.18
-0.15
-0.21
-0.3
-0.29
-0.33
-0.35
-0.34
-0.24
Book Value per Share
0.16
0.09
-0.18
-0.02
0.02
-0.02
0.01
0.11
0.08
-0.06
-0.08
-0.06
Tangible Book Value per Share
4
4
4
8
15
21
25
44
55
75
96
146
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-185.6
-436.9
-1,472.16
- -
-345.03
-50,574.91
-5,758.17
-37,785.35
-565,567.33
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
1
Depreciation Expense
- -
- -
- -
- -
-1
-2
-3
-5
-6
-8
-7
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-351.3
-473.03
-1,945.28
- -
-345.6
-49,489.11
-6,326.44
-33,861.53
-582,934.85
- -
- -
- -
Profit Margin (%)
1
- -
-1
- -
- -
- -
- -
5
2
-4
-9
-9
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
- -
- -
LT Debt
1
- -
-1
- -
1
1
1
5
5
-2
-5
-6
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
Capital Structure
CAD
•
in mil. unless spec.
Sep'11
Dec'11
Mar'11
ST Debt
6
6
6
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
138
163
163
Market Capitalization
1
5
6
Working Capital
CAD
•
in mil. unless spec.
Sep'11
Dec'11
Mar'11
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
9
9
9
Payables & Accruals
3
3
3
ST Debt
6
6
6
Deferred Revenue
- -
- -
- -
Growth Rates
CAD
•
in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Total Equity
9.54%
93.42%
167.36%
Free Cash Flow
76.21%
35.1%
-52.89%
Net Income, GAAP
70.75%
28.9%
-16.57%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -
Quarterly Revenue
CAD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
Quarterly Earnings Per Share
CAD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2009
-0.03
-0.02
-0.03
- -
-0.11
2010
-0.02
-0.02
-0.02
- -
-0.07
2011
-0.01
-0.01
- -
- -
- -
Quarterly Dividends Per Share
CAD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
Similar Companies
Business
Toronto
London
Frankfurt
Dubai
Mumbai
Hong Kong
Seoul
Tokyo
Unlock non-US companies
Get Access
Already premium?
Sign in
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Legends:
Stock price
Beta (1.0 Market)
% total return 10/23
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34